Xenon granted 24,250 options and 14,250 RSUs to 9 new employees; options were set at $37.54 per share, the grant-day closing price, and vest over 4 years. The awards could add shares over time, but the report gives no business results or share-count comparison showing a change in Xenon's outlook.
The awards give new hires a stake in Xenon, and some could become additional shares over time. The report gives no change to the company's results or plans, so it does not show a change in the business outlook.
Follow Xenon Pharmaceuticals Inc. (XENE) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for XENE